Sign in Create account

Medplus Health Services Limited

Consumer Services · Retailing

NSE: MEDPLUS BSE: 543427
₹654.90
▲ 0.90 (0.14%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
67/100
Moderate
Valuation
27/100
Expensive
Momentum
47/100
Neutral

QVM read Mixed signals Quality Moderate, Valuation Expensive, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹7,868 Cr
PE (TTM)
118.4
Industry median 38.7 (39 companies)
Price to Book
4.0
PEG (TTM)
2.5
Institutions holding %
44.33%
FII + DII, latest filed period
Piotroski Score
5
Relative return vs Nifty50, qtr %
-15.7
Relative return vs Sector, qtr %
-6.7
Free Cash Flow
₹373 Cr
as of March 31, 2026
Industry median ₹1 Cr (69 companies)
EPS Growth (YoY)
28.32%
as of June 30, 2026
Industry median 7.14% (47 companies)
Net Profit Growth (TTM)
48.62%
as of June 30, 2026
Industry median 19.53% (42 companies)
Operating Revenue Growth (TTM)
25.14%
as of June 30, 2026
Industry median 10.76% (43 companies)
Profit Growth (YoY)
28.95%
as of June 30, 2026
Industry median 8.70% (47 companies)
Revenue Growth (YoY)
21.08%
as of June 30, 2026
Industry median 13.18% (45 companies)
Current Ratio
3.00
as of March 31, 2026
Industry median 2.01 (67 companies)
Debt to Equity
0.00
as of March 31, 2026
Industry median 0.04 (54 companies)
Interest Coverage
11.56
as of June 30, 2026
Industry median 5.12 (51 companies)
Net Margin
7.84%
as of June 30, 2026
Industry median 6.65% (48 companies)
Operating Margin (EBIT)
11.34%
as of June 30, 2026
Industry median 8.41% (50 companies)
Operating Margin (TTM)
10.77%
as of June 30, 2026
Industry median 7.79% (51 companies)
Return on Assets
5.58%
as of March 31, 2026
Industry median 4.36% (49 companies)
Return on Capital Employed
12.20%
as of March 31, 2026
Industry median 11.79% (48 companies)
Return on Equity
11.12%
as of March 31, 2026
Industry median 9.52% (48 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

5 of 8 met
  • Yes Net profit is higher than a year earlier in each of the last 4 quarters
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Piotroski F-score is 7 or more (score 5)
  • Yes Debt to equity is below 0.5 (0.00)
  • No Return on equity is 15% or more (11.1%)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

2 of 4 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • No Promoter holding rose or was unchanged in the latest quarter
  • No Promoter pledge is 5% of their holding or less and not rising (60.7% pledged)
  • Yes Insiders have not sold in the past 3 months (no open-market sale filed in the last 3 months)

Peer comparison

3 of 3 met
  • Yes 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

1 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Undervalued (below its own historical PE range))
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
0.1%
Low 654.5000 · High 661.7500
1W return
-1.1%
Low 647.0000 · High 661.7500
1M return
-2.6%
Low 645.0000 · High 691.3500
52W return
-11.7%
Low 645.0000 · High 1022.2000
Lifetime High ₹1290.0000 (Jan. 20, 2022)
Lifetime Low ₹576.3000 (Nov. 9, 2022)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish0
Bearish6
5D
654.9
10D
656.4
20D
661.1
50D
690.5
100D
734.4
200D
802.1

Delivery and volume

Day avg. delivery
58.1%
Week avg. delivery
66.2%
Month avg. delivery
62.5%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

657.05
Pivot
First resistance659.60
Second resistance664.30
Third resistance666.85
First support652.35
Second support649.80
Third support645.10
Day RSI41.9
Day MFI52.2
Day MACD-8.36
Day MACD signal-9.95

Beta

1M0.54
3M0.58
1Y0.50
3Y0.46

Price change analysis

↓ -2.6%
Over 1 Month
LowHigh
645.00691.35
↓ -19.8%
Over 3 Months
LowHigh
645.00830.25
↓ -20.9%
Over 6 Months
LowHigh
645.001022.20
↓ -11.7%
Over 1 Year
LowHigh
645.001022.20
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 118.4 (own history: 146.6–799.8)
Undervalued (below its own historical PE range)

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹223 Cr
Net profit (June 30, 2026)
₹17 Cr
Basic EPS (June 30, 2026)
₹1.4500

Ranks #17 of 52 in Retailing by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter40.19%
  • Mutual funds24.51%
  • FII/FPI14.38%
  • Other DII5.44%
  • Public15.44%

Largest holders

NameCategoryShares %Shares
LONE FURROW INVESTMENTS PRIVATE LIMITEDPromoter14.3800%17280732
AGILEMED INVESTMENTS PRIVATE LIMITEDPromoter13.0300%15649495
MADHUKAR REDDY GANGADIPromoter12.7800%15350400
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA PHAPublic7.3200%8789314
ICICI PRUDENTIAL PHARMA HEALTHCARE AND DIAGANOSTICPublic4.9300%5918803

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings decreased from 40.22% to 40.19% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings decreased from 15.53% to 14.38% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings increased from 22.60% to 24.51% in Jun 2026 qtr

13 mutual fund schemes also hold this stock.

All shareholding details →

Insider trading, SAST & pledges

All 20 insider trades, 28 SAST, 23 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
26 Dec 2025 AGILEMED INVESTMENTS PRIVATE LIMITED Promoter Pledge Revoke 0 ₹339.85 Cr
3 Jan 2025 Lone Furrow Investment Private Limited Promoter Pledge 0 ₹41.59 Cr
3 Jan 2025 MADHUKAR REDDY GANGADI Promoter Pledge 0 ₹162.49 Cr
30 Dec 2024 Lone Furrow Investment Private Limited Other Pledge Revoke 0 ₹1,288.56 Cr
24 Dec 2024 MADHUKAR REDDY GANGADI Other Pledge 0 ₹1,162.91 Cr
17 Feb 2024 AGILEMED INVESTMENTS PRIVATE LIMITED Promoter Pledge 0 ₹21.83 Cr
17 Feb 2024 Lone Furrow Investments Private Limited Promoter Pledge 0 ₹36.21 Cr
15 Feb 2024 Lone Furrow Investments Private Limited Promoter Pledge 0 ₹89.70 Cr
15 Feb 2024 AGILEMED INVESTMENTS PRIVATE LIMITED Promoter Pledge 0 ₹13.65 Cr
15 Feb 2024 Lone Furrow Investments Private Limited Promoter Pledge 0 ₹27.57 Cr

All insider and SAST disclosures →

Deals (Bulk & Block)

All 30 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
3 Nov 2025 GRAVITON RESEARCH CAPITAL LLP Bulk Buy 673,825 836.7400 NSE
3 Nov 2025 GRAVITON RESEARCH CAPITAL LLP Bulk Sell 673,497 837.3900 NSE
18 Nov 2024 SBI MUTUAL FUND Block Sell 1,000,000 700.0000 NSE
18 Nov 2024 PI OPPORTUNITIES FUND - I Block Sell 6,893,583 700.0000 NSE
18 Nov 2024 MORGAN STANLEY ASIA SINGAPORE PTE Block Buy 142,858 700.0000 NSE
18 Nov 2024 KOTAK MAHINDRA MUTUAL FUND Block Buy 3,071,429 700.0000 NSE
18 Nov 2024 INVESCO MUTUAL FUND Block Buy 3,071,429 700.0000 NSE
18 Nov 2024 FRANKLIN TEMPLETON MUTUAL FUND Block Buy 1,607,867 700.0000 NSE
18 Nov 2024 SBI MUTUAL FUND Bulk Sell 1,000,000 700.0000 NSE
18 Nov 2024 PI OPPORTUNITIES FUND - I Bulk Sell 6,893,583 700.0000 NSE

All bulk and block deals →

Corporate Actions

Full history (1 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from Medplus Health Services Private Limited to Medplus Health Services Limited

All corporate actions →

Board Meetings

View board meeting history →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
21 Jul 2026 Financial Results Yes
29 May 2026 Financial Results Yes
20 May 2026 Financial Results/Other business matters Yes
30 Jan 2026 Financial Results Yes
31 Oct 2025 Financial Results Yes

Corporate Announcements

All 774 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
3 Oct 2026 Certificate under SEBI (Depositories and Participants) Regulations, 2018 Medplus Health Services Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
3 Oct 2026 Credit Rating Medplus Health Services Limited has informed the Exchange about Credit Rating
3 Oct 2026 Company Update Medplus Health Services Ltd - 543427 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
3 Oct 2026 Company Update Medplus Health Services Ltd - 543427 - Announcement under Regulation 30 (LODR)-Credit Rating
28 Sep 2026 Insider Trading / SAST Medplus Health Services Ltd - 543427 - Closure of Trading Window
28 Sep 2026 Trading Window Medplus Health Services Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
28 Sep 2026 Board Meeting Medplus Health Services Ltd - 543427 - Board Meeting Intimation for The Quarter And Half-Year Ended September 30, 2026.
10 Sep 2026 Company Update Medplus Health Services Ltd - 543427 - Board Comments On Fine Levied By The Exchange
10 Sep 2026 Others Medplus Health Services Ltd - 543427 - Board Meeting Outcome for Outcome Of Board Meeting Under SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (Listing Regulations)
10 Sep 2026 Updates Medplus Health Services Limited has informed the Exchange regarding 'Board comments on fine levied by the Exchange'.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.00)
  • Comfortable interest coverage (11.6x)
  • Strong revenue growth YoY (21.1%)

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

  • PE above 35 (118.4) -- priced for continued strong execution

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Medplus Health Services Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.